Man Group
AMED

Man Group’s Amedisys AMED Stock Holding History

Man Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-248,400
Closed -$24.4M – 2197
2025
Q2 		$24.4M Buy
248,400
+120,000
+93% +$11.4M 0.05% 433
2025
Q1 		$11.9M Buy
128,400
+58,400
+83% +$5.38M 0.03% 660
2024
Q4 		$6.36M Buy
+70,000
New +$6.43M 0.02% 918

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Man Group's AMED Position: Q3 2025 in Review

Man Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 69,198 shares — an estimated $6.81M sold.

Man Group first reported a position in AMED in Q1 2018 and held it in 21 quarters. The position peaked at $41.5M in Q2 2019. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Man Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Man Group sold 69,198 Amedisys shares in Q3 2025, an estimated $6.81M.
  • Man Group first reported a position in Amedisys in Q1 2018 and held it in 21 quarters.
  • Man Group's Amedisys position peaked at $41.5M in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.